Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11439329Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award categories
- Obstetrics & Gynecology
NIH Funding · FY2025
Linked Award Amount
$2.3M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#5,461
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Canhua Xiao as a PI. Multi-PI records show the full award amount for context.
- 5R01DE032243-04R01Oral microbiome and periodontal diseases in oral HPV infection among people living with HIV$780.4Kaward amount
- 5R01NR020188-04R01The Role of the Gut Microbiome and Short Chain Fatty Acids in the Regulation of Inflammation and Neuropsychological Symptoms in Patients with Head and Neck Cancer$746.6Kaward amount
- 5R01CA281873-02R01Biological and social determinants of psychosocial sequelae in advanced head and neck cancer survivors receiving immunotherapy$658.4Kaward amount
- $79.6Kaward amount
Award organization
Organizations that administered FY2025 awards listing Canhua Xiao as a PI.
FY2025 award administered by Emory University (GA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardEmory University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #2391
- 2024Entered Top 25% NationallyRanked #2391
- 2024R01 Grant Holder
- 2025$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Canhua Xiao.